NCT04783090View on ClinicalTrials.gov

MT1013 Clinical TRIAL In Healthy Subject

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 28, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

March 17, 2022

Conditions

Healthy Volunteer

Interventions

DRUG

MT1013

bispecific peptide as a CaSR agonist and a functional OGP analogue

Trial Locations (1)

90630

WCCT Global, Inc., Cypress

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

WCCT Global

INDUSTRY

lead

Shaanxi Micot Pharmaceutical Technology Co., Ltd.

INDUSTRY

NCT04783090 - MT1013 Clinical TRIAL In Healthy Subject | Biotech Hunter | Biotech Hunter